Stocks In Focus

Technical Forecasts for TSTR, RNN, and RODM

Charts of TerreStar Corporation, Rodman & Renshaw Capital Group, and Rexahn Pharmaceuticals are sliced and diced.

Published: October 26, 2009 @ 9:12 AM PDT
Rating N/A

The stock market made a complete about-face a few moments ago, slipping into the red with no warning. The move accents the need for traders to focus only on the best of the best ideas, like Rexahn Pharmaceuticals, Inc. (AMEX:RNN), Rodman & Renshaw Capital Group Inc. (NASDAQ:RODM), and TerreStar Corporation (NASDAQ:TSTR). Let's review each chart in-depth.

Look out below if you're an owner of Rodman & Renshaw Capital Group Inc. (NASDAQ:RODM). At the point in time this write-up was begun, the stock was trading at $5.01. Now it's at $4.66, and still tumbling.

Nobody can say the implosion was a complete surprise. Rodman & Renshaw Capital shares started to hit a headwind with resistance at $6.40, and a couple of waves of distribution inspired current owners to start taking profits on RODM (if which there were plenty).

As for where RODM could end up bottoming, notice there's a major Fibonacci line at $4.46 that was also a support area - briefly - in early September. If that line snaps though, Rodman & Renshaw doesn't have another support level until $3.11.

In the bigger picture though (take a look at a weekly chart), the shift to a bearish phase is crystal clear.



----------------------------------------------------------------------
Sign-up for Free to Receive Future Commentary
and Trading Alerts on RNN, RODM, and TSTR.

----------------------------------------------------------------------

Rexahn Pharmaceuticals, Inc. (AMEX:RNN) is hanging by a thread.... and the thread is starting unravel.

If the name rings a bell, it might be because we posted a bearish view of Rexahn Pharmaceuticals back on October 20th. RNN shares were trading at $0.71 at the time, but we suggested the major outside bearish day form the 19th was a bearish omen. The stock's at $0.69 today.... which isn't a lot lower, but the persistence of the bears is taking a toll.

The key here - for better or worse - is the support at $0.68. That's where Rexahn Pharmaceuticals has found a floor since our chat on 20th, and it's also where RNN shares found support back in July. In other words, it's a pretty important line in the sand. When/if it snaps though, a lot of bearishness is going to be unleashed in a short amount of time.



Misery may finally be over for TerreStar Corporation (NASDAQ:TSTR) owners.... or not. The stock's at a major inflection point as of right now, though the question hasn't been unanswered yet.

Just for the record, I warned you of this pullback back on September 30th. The stock's surge was just too hot to handle, and sure enough, TerreStar Corporation fell back from my warning level of $2.55 (after a peak at $2.95) that day to the current price of $1.39 - you can thank me later.

Now, however, TerreStar is resting in the support line I traced then... the one extending through the lows going back to June that formed the primary wedge pattern. I'm still not convinced this will be the rebound point, but I find it suspicious this is where TSTR has halted the decline.

Bottom line? Keep TSTR on your watchlist, and I will too. I think this one is going to be trade-worthy soon. I'll let you know via the newsletter.



If you'd like to know of any changes in our opinion of TSTR, RNN, and RODM (or if we officially recommend them as trades), be sure to sign up for our free newsletter today. It's delivered 2 to 3 times per week.

Rate It : 1 2 3 4 5

Post a Comment
 

Title of the comment

Content of the comment

 
Bookmark and Share

Get the SCN
Newsletter Today!

Find out WHAT's Hot and What's Not from Top Traders and Investors.

Gain Insight into Which Small Cap Growth Stocks Have the Potential for Monster Returns.

Identify Market Trends and Changes Before the Rest of the Crowd.

Whitelist Us

Having Trouble Getting Our Email Newsletter?  Whitelist Us.

Click here for more info...

Oct 16, 2009 @ 12:44 PM PDT
When the recession hit, Audiovox was already in the process of cutting its fat, whereas other companies were only just beginning.
Rating N/A

Thursday January 21, 2010 10:50 PM GMT
As incredible as it may seem, despite the 2.3% tumble we’ve seen the PowerShares QQQ Trust (ETF) (NASDAQ:QQQQ) suffer over the last week and a half, the fund is still not in a heap of technical trouble…. at least not on the surface. If you look at the bigger picture of the underlying market though, [...]
Wednesday January 20, 2010 4:54 PM GMT
The SPDR S&P 500 ETF (NYSE:SPY) has just broken a seven-month support line. Though the relatively unharmful 1.7% dip today hasn’t unwound the bulk of the gains for that timeframe - or even the gains for the last couple of weeks - the weight of those gains has quietly been taking a toll on SPY. [...]
Wednesday October 28, 2009 4:35 PM GMT
If you’re a fan of trading the SPDR S&P 500 Fund (NYSE:SPY), or any index vehicle for that matter, you may want to put your bearish hat on. It’s no secret that the market’s been sinking for the last few days - we’ve seen plenty of ebb and flow since March. What traders may not [...]
Monday March 30, 2009 2:50 PM GMT
Wow. It’s not too often stocks lose a collective 3% within the first 5 minutes of trading. I suspected we were due for a nasty pullback (the kind of dip I forecasted on Thursday), and sure enough, here it is. The S&P 500 has now given up 4.8% from Thursday’s high. Is this enough to [...]
SCN Newsletters
Saturday February 6, 2010 11:48 AM PST
The bulls certainly fought back hard in the second half of Friday's session, turning yet-another big loss into fairly decent gains. Was this the reversal sign we've been waiting for, or merely a fake-out move? Thoughts on the matter are below. First though, highlights from this week's community commentary...
Friday January 29, 2010 11:37 AM PST
Power3 Medical Products (PWRM), First Regional Bancorp (FRGB), SPDR Trust S&P 500 Fund (SPY), ImmuneRegen Biosciences Holdings (IRBS), and Provident Financial Holdings (PROV) are reviewed in depth. After that, we take an updated look at our market forecast. Stocks in Focus Up-Trend Outlook: PROV...
Friday January 22, 2010 9:12 AM PST
Is New Leaf Brands Inc. (OTC:NLEF) going to follow in the footsteps of Cadbury and land a big suitor (at a premium)? Maybe. We'll check out this young and growing company below. First though, let's take a look at this week's 'best' of from the community pages. The shortened list looks at Hana Biosciences...

This community is currently in beta and is constantly undergoing active development.  Please be patient as we strive to bring you a usable, full-featured community that you will enjoy.  If you should have any questions, problems, suggestions, feature requests, rants, and/or raves, please do not hesitate to let us know by writing us as : webmaster@smallcapnetwork.com.